Company: XAIR
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021561
Chunk: 61

Company: Beyond Air, Inc.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 61
---
.9 million as compared to $7.2 million for the
three months ended September 30, 2024. The decrease of $2.3 million was attributed primarily to a decrease in spend in salaries $0.6
million ($0.4 million in Beyond Air and $0.2 million in Beyond Cancer), stock-based compensation costs $1.3 million ($0.6 million in
Beyond Air and $0.8 million in Beyond Cancer), $0.3 million of legal fees and $0.1 million of facility expenses, partially offset by
an increase of $0.1 million in royalties.

Selling,
general and administrative expenses for the six months ended September 30, 2025 were $9.6 million as compared to $14.4 million for the
six months ended September 30, 2024. The decrease of $4.8 million was attributed primarily to a decrease in spend in salaries $1.4 million
($1.1 million in Beyond Air and $0.3 million in Beyond Cancer), stock-based compensation costs $2.7 million ($1.3 million in Beyond Air
and $1.5 million in Beyond Cancer, partially offset by reduction of $0.1 million in NeuroNos), $0.4 million of legal fees, $0.1 million
marketing and advertising costs for Beyond Air, $0.1 million travel expenses, and $0.1 million of facility expenses, partially offset
by an increase of $0.2 million in royalties.

Other
Income/Expense

Other
expense for the three months ended September 30, 2025 were $0.6 million as compared to other expense of $1.2 million for the three months
ended September 30, 2024. The decrease in expense of $0.6 million was attributed primarily to the prior period loss associated with the
partial extinguishment of debt of $0.6 million. The derivative liability was extinguished in the prior year and no fair value measurement
of such instrument occurred during the current period. Additionally, the decrease in interest expense of $0.3 million is due to the Company’s
current debt facility compared to the debt outstanding in the comparative period.

Other
expense for the six months ended September 30, 2025 were $1.1 million as compared to other expense of $0.7 million for the six months
ended September 30, 2024. The increase in expense of $0